Oxford Genetics Signs Supply & Licensing Deal

Will leverage its CRISPR engineered mammalian cell lines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Oxford Genetics has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical community. As part of the agreement, Oxford Genetics will leverage its high throughput automated genomic engineering platform for CRISPR modification of mammalian cell lines. “This contract highlights Oxford Genetics’ commitment to providing the highest quality cell line engineering services to its global cus...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters